Azenta Life Sciences
Business Services · Massachusetts, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
200 Summit Dr, Burlington, Massachusetts...Phone Number
(978) 262-2626Website
www.azenta.comRevenue
$596.5 MillionStock Symbol
AZTAIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
4
1
6
2
2
About Azenta Life Sciences
Azenta Life Sciences (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to get to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally. Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe, and Asia.Explore more
Azenta Life Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Azenta Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Azenta Life Sciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Azenta Life Sciences
Azenta Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Azenta Life Sciences launches new products
Check out if Azenta Life Sciences is spiking on competitors!
Funding: Get notified immidiatlly once Azenta Life Sciences has new funding data
Check if Azenta Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Azenta Life Sciences had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Azenta Life Sciences
Find 2 more new buyers
Compare Similar Companies to Azenta Life Sciences
Compare insights from companies similar to Azenta Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Azenta Life Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Azenta Life Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Azenta Life Sciences.
Azenta Life Sciences Tech Stack
A closer look at the technologies used by Azenta Life Sciences
Most Recent Scoops
Open Position
Open Position
Pain Point
Azenta Life Sciences has recorded non-cash goodwill impairment charges of $112.4 million for Multiomics and $36.6 million for Sample Management Solutions as part of its annual goodwill impairment assessment, driven by a sustained decline in stock price, a decrease in near-term outlook, and a more uncertain macroeconomic and geopolitical environment that reduced the estimated fair value of both units below their carrying value.
Earnings, Accounting, Financial Reporting, Finance, Risk
Project
Azenta Life Sciences has introduced its Lightning RNA-Seq offering in Multiomics, reducing turnaround time from approximately 20 days to 5 days, representing the fastest turnaround time currently available in the market.
Medical Research
Pain Point
Pain Point, Executive Moves, Funding, Sales, Finance
Azenta Life Sciences News & Media
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
BURLINGTON, Mass., May 21, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, demonstrating continued progress against its key ESG priorities. The report includes ESG data for the Company's...INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Azenta, Inc. - AZTA
NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...Levi & Korsinsky Announces Investigation of Securities Claims Against Azenta, Inc. (AZTA)
Azenta, Inc. reaffirmed 3%-5% organic revenue growth and 300 basis points of margin expansion in February 2026 -- then disclosed a $149 million goodwill impairment and slashed guidance three months later Azenta, Inc. reaffirmed 3%-5% organic revenue growth and 300 basis points of margin expansion in February 2026 -- then disclosed a $149 million goodwill impairment and slashed guidance three months laterAZTA Investors Have Opportunity to Join Azenta, Inc. Fraud Investigation with the Schall Law Firm
AZTA Investors Have Opportunity to Join Azenta, Inc. Fraud Investigation with the Schall Law Firm
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Azenta Life Sciences
Sign Up For FreeTo access detailed company insights
Azenta Life Sciences (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to get to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research, and advanced cell thera... Read More
